Conversely, the presence of middle or high methylation levels in the SPON2 promoter leads to diminished expression of SPON2, which exhibits a strong association with favorable outcomes among patients diagnosed with acute lymphoblastic leukemia (24). Here, SPON2 is linked to acute lymphoblastic leukemia.